肿瘤免疫监视新机制探究:IFN-γ诱导肿瘤干细胞休眠

基本信息
批准号:81502473
项目类别:青年科学基金项目
资助金额:19.00
负责人:刘玉英
学科分类:
依托单位:中国医学科学院基础医学研究所
批准年份:2015
结题年份:2018
起止时间:2016-01-01 - 2018-12-31
项目状态: 已结题
项目参与者:梁晓雨,张华锋,尹晓南,董文茜
关键词:
C20_皮肤及黑色素瘤肿瘤休眠免疫监视IFNγ23双加氧酶
结项摘要

More and more evidences from clinical and preclinical studies showed that tumor dormancy exists. However, the underlying mechanism involved in tumor dormancy is extremely limited. The immunosurveillance of immune system on tumor is mainly due to the elimination of tumor. It is very important to know whether immune system could regulate tumor dormancy in the field of tumor immunity. We previously found an effective method to isolate and amplify tumor stem cells in vitro by soft 3D fibrin gel. By using soft 3D fibrin gel system, we found that conditioned medium from activated tumor specific CD8+T cells induced B16 melanoma stem-like cells into dormancy, suggesting that tumor specific immune response can regulate tumor dormancy by releasing some kinds of cytokines. Further study showed that IFN-γinduced B16 stem cells into dormancy which was inhibited by the antagonist of indoleamine 2,3- dioxygenase (IDO1). Moreover, kynurenine (the intermediated product of tryptophan metabolism catalyzed by IDO1) also induced tumor stem cells into dormancy. Based on the above results, we hypothesize that IFN-γregulated tumor stem cell dormancy through the IDO signalling pathway. This project will help us understand how immune system monitors tumor dormancy, which will open new avenues for therapeutic intervention against tumor.

越来越多的临床及临床前期研究证明肿瘤休眠状态的存在,然而迄今为止,肿瘤休眠发生机制依然不清。免疫系统对肿瘤的监视作用往往归因于其对肿瘤细胞的杀伤,是否免疫系统能够调节肿瘤休眠是肿瘤免疫领域一个非常值得探究的课题。申请者所在课题组前期建立了纤维蛋白三维软胶筛选、扩增肿瘤干细胞技术,利用该技术申请人发现,肿瘤特异性CD8+ T细胞激活后的上清液能够导致B16黑色素瘤干细胞进入休眠,表明肿瘤特异性免疫反应可以通过释放某类因子调节肿瘤干细胞的休眠。进一步研究发现,IFN-γ可诱导B16干细胞进入休眠,且能够被吲哚胺2,3-双加氧酶(IDO1)抑制剂所打破。IDO1催化色氨酸代谢的中间产物犬尿氨酸也能诱导肿瘤干细胞进入休眠。基于此,本课题推测IFN-γ通过吲哚胺2,3-双加氧酶信号通路调节肿瘤干细胞休眠。本课题的开展将有助于回答机体免疫系统是如何监视肿瘤休眠这一基本问题,为免疫防控肿瘤提供新思路。

项目摘要

肿瘤细胞休眠是肿瘤研究领域的谜团,被认为是临床肿瘤复发和转移的关键环节,目前对于其形成机理完全不清楚。课题组利用前期所建立的三维纤维蛋白软胶(soft 3D fibrin gels)技术,成功地在体外建立起免疫诱导的肿瘤再生细胞休眠模型。利用该休眠模型该课题组发现,对于分化的肿瘤细胞IFN-γ通过STAT1信号通路激活caspase 3和caspase 7导致细胞凋亡;但是对于肿瘤再生细胞(TRCs)而言,IFN-γ却上调IDO1和AhR表达,AhR作为转录因子直接上调p27的表达,p27作为细胞周期抑制因子,一方面阻断细胞增殖,另一方面又可以与STAT1相结合,抑制STAT1的活性以及STAT1介导的细胞凋亡,从而使细胞进入休眠状态。然而,通过阻断IDO1/AhR代谢通路以阻断p27的上调表达,能够恢复IFN-γ-STAT1信号通路传导的凋亡信号,导致杀伤休眠的TRCs。这一全新机理的阐明,为目前克服临床上不能被清除的休眠的肿瘤种子细胞提供了新的方向,并为肿瘤免疫治疗开辟了新途径。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
3

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

DOI:10.11999/JEIT150995
发表时间:2016
4

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
5

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017

刘玉英的其他基金

批准号:50606004
批准年份:2006
资助金额:26.00
项目类别:青年科学基金项目
批准号:81773062
批准年份:2017
资助金额:58.00
项目类别:面上项目

相似国自然基金

1

IFN-γ诱导非小细胞肺癌肿瘤干细胞富集的机制研究

批准号:81872410
批准年份:2018
负责人:王丽萍
学科分类:H1810
资助金额:53.00
项目类别:面上项目
2

IFN-β激活IDO1-Kyn-AhR信号通路调节肿瘤再生细胞休眠

批准号:81773062
批准年份:2017
负责人:刘玉英
学科分类:H1806
资助金额:58.00
项目类别:面上项目
3

碳酸锂抗肿瘤新机制探究:调节糖原代谢再教育肿瘤相关巨噬细胞

批准号:81802847
批准年份:2018
负责人:解静
学科分类:H1806
资助金额:20.50
项目类别:青年科学基金项目
4

肿瘤微环境调控肝癌干细胞休眠与激活的机制研究

批准号:81772554
批准年份:2017
负责人:关新元
学科分类:H1819
资助金额:58.00
项目类别:面上项目